Ceftaroline fosamil treatment patterns and outcomes in adults with community-acquired pneumonia: a real-world multinational, retrospective study.
Alex SorianoMatteo BassettiCharalambos GogosTristan FerryRaul de PabloWajeeha AnsariMichal KanteckiBernd SchweikertGustavo LunaFrancesco BlasiPublished in: JAC-antimicrobial resistance (2024)
Ceftaroline fosamil was effective in treating adults with CAP, including severe CAP, in Europe and Latin America. Clinical response to ceftaroline fosamil was associated with reductions in healthcare resource use compared with non-responders.